Gidsen 

What would count as evidence of a pore?

The useful answer is that the pore explanation is a hypothesis with experimental observations behind it, not a settled account of every pad treatment. It asks a structural question about the membrane of an adipocyte—a fat cell. A smaller waist measurement asks a different question.

To connect the two, research would need to show the membrane change under the relevant exposure, identify what leaves the cell, and establish that this process explains the measured result in people. A result at one step cannot fill in the rest of that chain. The studies below address different steps. [1] [2] [3]

This is an evidence-reading framework, not a diagram of a proven biological pathway.

Where the claim started: Neira's tissue microscopy

Neira and colleagues' 2002 paper, Fat Liquefaction: Effect of Low-Level Laser Energy on Adipose Tissue, investigated a 635 nm diode laser in a lipoplasty context. It examined abdominal fat specimens from 12 healthy women, including tissue exposed through skin before removal and extracted samples irradiated without tumescent solution. Tumescence refers here to the solution introduced into tissue as part of the surgical technique. [1]

The authors used scanning and transmission electron microscopy and interpreted membrane disruptions as transient pores associated with lipid leaving cells. This was a microscopy claim, not just an inference from a tape measure. However, the images were of processed specimens; they were not a live recording of a consumer pad opening and closing pores. The surgical context and the use of tumescence also limit transfer to an external pad used on intact skin without that intervention. [1]

A published image can support a reported observation while leaving its general applicability unresolved. The relevant question is whether the same process is demonstrated with the device and conditions being discussed.

What the later cell experiments measured

Caruso-Davis and colleagues studied the LAPEX 2000 LipoLaser, described as emitting 635–680 nm light. In separate cultured human adipocyte experiments, cell viability was similar after laser and control exposures, but the calcein dye signal was lower after irradiation. The authors considered leakage a possible explanation; this assay did not directly image a pore. [2]

Triglyceride in the culture fluid increased with laser exposure when human serum, including heat-inactivated serum, was present; the corresponding response was absent without added human serum. Glycerol did not increase in a way supporting stimulated lipolysis. Lipolysis means triglyceride breakdown, which differs from release of intact triglyceride. These findings supported a conditional release hypothesis, not a complete human pathway. [2]

Jankowski and colleagues later pointed out that altered cellular dye transport could also explain reduced calcein staining. That alternative was not established by their clinical study either. A dye change is therefore evidence to interpret, not a unique fingerprint of pores. [3]

Why human findings complicate the explanation

The Caruso-Davis clinical arm randomized 40 non-obese adults to active or inactive treatment over four weeks. Photographic ratings favored active treatment; the four-week waist comparison was significant in the weight-stable subset, but not in the analysis regardless of weight change. Manufacturer funding and short follow-up matter when interpreting this result. Neither endpoint visualized pores. [2]

Jankowski's study used a different system: 650 nm Mimari contact panels. It enrolled 24 non-obese adults; 17 had follow-up ultrasound imaging. After six treatments over two weeks, with imaging two weeks later, treated-side fat-thickness changes were not statistically significant. Adjusting for the untreated side produced a net increase in eight participants. This challenged the proposed local mechanism but did not prove that every optical system fails. The small sample and attrition limit certainty. [3]

The two studies do not measure the same outcome with the same hardware. Circumference, appearance, imaging thickness and weight should remain separate. An improvement in one cannot be relabeled as proof of another.

A 2025 systematic review reported favorable circumference findings across three randomized trials. Its publisher abstract was accessible; the full review was not verified here. Its tape-measure outcome does not settle a membrane mechanism. [5]

Where does any released lipid go?

The cited original studies do not directly trace pad-mobilized lipid through a living person to its final destination. The lymphatic and metabolic account discussed by Caruso-Davis is an inference, not a measured clearance experiment. Jankowski's proposed systemic explanation is also a hypothesis. [2] [3]

Separate three questions when reading a claim: Did lipid leave a cell? Did it leave the treated region? Was it permanently removed from the body? Even a convincing answer to the first would not establish the other two.

These papers do not justify a promised urine or sweat pathway, a detox instruction, a fixed clearance timeline or permanent fat loss. Nor does a circumference measurement establish weight loss. FDA describes non-invasive body contouring as distinct from weight-loss treatment. [4]

How to read the pore claim

Ask which experiment supports the claim, which device was tested and which outcome was measured. The evidence supports discussing a proposed pore mechanism with clear limits. It does not support presenting pores, lipid clearance and lasting body change as one established sequence for every pad.